87 FR 245 pgs. 78638-78639 - Foreign-Trade Zone (FTZ) 35—Philadelphia, Pennsylvania, Authorization of Production Activity, Piramal Pharma Solutions (Pharmaceutical Products), Sellersville, Pennsylvania
Type: NOTICEVolume: 87Number: 245Pages: 78638 - 78639
Pages: 78638, 78639Docket number: [B-37-2022]
FR document: [FR Doc. 2022-27836 Filed 12-21-22; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-37-2022]
Foreign-Trade Zone (FTZ) 35-Philadelphia, Pennsylvania, Authorization of Production Activity, Piramal Pharma Solutions (Pharmaceutical Products), Sellersville, Pennsylvania
[top] On August 19, 2022, Piramal Pharma Solutions submitted a notification of proposed production activity to the FTZ
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (87 FR 52505-52506, August 26, 2022). On December 19, 2022, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: December 19, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-27836 Filed 12-21-22; 8:45 am]
BILLING CODE 3510-DS-P